Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02583360 · ClinicalTrials.gov registry record · NA
Mechanisms and Management of Infant Dysphagia
A NA study, sponsored by Sudarshan Jadcherla.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT02583360: Completed NA study, sponsored by Sudarshan Jadcherla.
NCT02583360 is a NA study that has completed, run by Sudarshan Jadcherla. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02583360, a NA study, has completed, sponsored by Sudarshan Jadcherla.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
The purpose of the investigator's study is to evaluate the causes of feeding difficulty in infants. New treatments can be possible only if the cause is known. In this study, the investigator plans to evaluate the movement of the muscles in an infant's mouth, throat (pharynx) and food pipe (esophagus) that are responsible for moving the food down into the stomach and that help protect an infants airway.
Primary Outcome
The primary endpoint is the feeding success defined as full oral feeding (no tube feeds feeds) without symptoms that require interventions
Interventions
- DIAGNOSTIC_TEST Combined testing (diagnostic VFSS + research HRM) + Parent Preferred Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2015-10-02 |
| Est. Completion | 2020-08-30 |
| Phase | NA |
What the finished NCT02583360 record still lists
NCT02583360 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Combined testing (diagnostic VFSS + research HRM) + Parent Preferred Therapy is the first listed.
NCT02583360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02583360 about?
NCT02583360 is a clinical study titled "Mechanisms and Management of Infant Dysphagia". The purpose of the investigator's study is to evaluate the causes of feeding difficulty in infants. New treatments can be possible only if the cause is known. In this study, the investigator plans to evaluate the movement of the muscles in an infant's mouth, throat (pharynx) and food pipe (esophagus...
What is the current status of trial NCT02583360?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2015-10-02. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT02583360?
The interventions under investigation include: Combined testing (diagnostic VFSS + research HRM) + Parent Preferred Therapy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02583360?
This trial is sponsored by Sudarshan Jadcherla, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02583360's enrollment target sits among peer trials
109 825th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI